Dimerix strikes $120m licensing deal for kidney drug in Middle East
Dimerix strikes $120m licensing deal for kidney drug in Middle East
Source: stockhead.com.au
Advanz Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Advanz Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Advanz Pharma Today - Breaking & Trending Today
Dimerix and Taiba enter DMX-200 commercialisation deal in Middle East
Taiba will oversee the complete sales and expenditures linked to the marketing of the product.
Source: yahoo.com
Teva Pharmaceutical Industries Limited: Teva and Alvotech Announce SIMLANDI (adalimumab-ryvk) Injection Now Available in the U.S.
SIMLANDI is the first interchangeable high-concentration, citrate-free biosimilar to Humira Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and
Source: finanznachrichten.de
Dr. Reddy's Laboratories Ltd.: Alvotech and Dr. Reddy's Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia & Xgeva in the U.S., Europe and UK
Dr. Reddy's gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK) Alvotech will be responsible for development
Source: finanznachrichten.de